At 6.2% CAGR, the South & Central America Arterial Blood Gas Kits Market is Projected to be Worth US$ 59.01 million by 2030, says The Business Market Insights

According to the Business Market Insights’ research, the South & Central America arterial blood gas kits market was valued at US$ 36.34 million in 2022 and is expected to reach US$ 59.01 million by 2030, registering a CAGR of 6.2% from 2022 to 2030. Increasing prevalence of respiratory diseases and growing prevalence of metabolic and kidney diseases are the critical factors attributed to the South & Central America arterial blood gas kits market expansion.

Arterial blood gas kit manufacturers are adopting developmental strategies such as partnerships, collaborations, product launches, approvals, and mergers and acquisitions to sustain the competitive environment and strengthen their presence in the arterial blood gas kits market. Inspira Technologies developed a noninvasive HYLA blood sensor. The sensor is designed to perform real-time blood monitoring to alert physicians immediately regarding the signs of changes in a patient's clinical condition.

Medical equipment manufacturers across the world are scaling up the production of their devices. Their involvement in various business developments and product innovations helps ensure the easy availability of the products in the South & Central America markets. Moreover, the regulatory agencies are providing the required support through timely product approvals and permissions. Roche launched a CE-approved new blood gas digital solution to enhance patient care. Therefore, rising strategic activities by manufacturers are expected to propel the arterial blood gas kits market growth in the coming years.

On the contrary, risks, complications, and sampling errors associated with arterial blood sampling hurdles the growth of South & Central America arterial blood gas kits market.

Based on product, the South & Central America arterial blood gas kits market is segmented into luer lock syringe and luer slip syringe. The luer lock syringe segment held 73.1% share of South & Central America arterial blood gas kits market in 2022, amassing US$ 26.57 million. It is projected to garner US$ 45.50 million by 2030 to expand at 7.0% CAGR during 2022–2030.

Based on type, the South & Central America arterial blood gas kits market is segmented into vented and non-vented. The non-vented segment held 77.7% share of South & Central America arterial blood gas kits market in 2022, amassing US$ 28.24 million. It is projected to garner US$ 47.09 million by 2030 to expand at 6.6% CAGR during 2022–2030.

Based on usage, the South & Central America arterial blood gas kits market is segmented into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held 80.4% share of South & Central America arterial blood gas kits market in 2022, amassing US$ 29.20 million. It is projected to garner US$ 49.33 million by 2030 to expand at 6.8% CAGR during 2022–2030.

Based on application, the South & Central America arterial blood gas kits market is segmented into In vitro diagnostics, electrolyte analysis, and pH blood gas. The In vitro diagnostics segment held 41.9% share of South & Central America arterial blood gas kits market in 2022, amassing US$ 15.24 million. It is projected to garner US$ 25.91 million by 2030 to expand at 6.9% CAGR during 2022–2030.

Based on needle guage, the South & Central America arterial blood gas kits market is segmented into 23 G to 25 G and less than 23 G. The 23 G to 25 G segment held 71.7% share of South & Central America arterial blood gas kits market in 2022, amassing US$ 26.04 million. It is projected to garner US$ 43.47 million by 2030 to expand at 6.6% CAGR during 2022–2030.  

Based on syringe volume, the South & Central America arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3 ml segment held 44.9% share of South & Central America arterial blood gas kits market in 2022, amassing US$ 16.32 million. It is projected to garner US$ 27.20 million by 2030 to expand at 6.6% CAGR during 2022–2030.

Based on end user, the South & Central America arterial blood gas kits market is segmented into hospitals, clinics, and others. The hospitals segment held 51.3% share of South & Central America arterial blood gas kits market in 2022, amassing US$ 18.63 million. It is projected to garner US$ 30.58 million by 2030 to expand at 6.4% CAGR during 2022–2030.

Based on country, the South & Central America arterial blood gas kits market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 58.7% share of South & Central America arterial blood gas kits market in 2022. It was assessed at US$ 21.32 million in 2022 and is likely to hit US$ 35.65 million by 2030, exhibiting a CAGR of 6.6% during 2022–2030.

Key players operating in the South & Central America arterial blood gas kits market Becton Dickinson and Co, ICU Medical Inc, Siemens Healthineers AG, Radiometer Medical ApS, ITL health Group Ltd, Medline Industries LP, Cardinal Health Inc, Fisher Scientific International Inc, and Teleflex Inc, among others.  

• In April 2022, Siemens Healthineers has received U.S. Food and Drug Administration approval for RAPIDPoint 500e Blood Gas Analyzer. RAPIDLyte Arterial Sampling Syringes and RAPIDLyte Multicap Capillaries offered by Siemens are compatible with RAPIDPoint 500e Blood Gas System. This product approval strengthens the market position of the company.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com